MedTrace Logo

AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period

NCT05892341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 203

Last updated 2025-12-02

Study results available
· View outcomes & findings →

Summary

Study is to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing

Conditions

  • Venous Leg Ulcer
  • Diabetic Foot

Interventions

DEVICE

AQUACEL® Ag+ Extra™

Wound treatment with AQUACEL® Ag+ Extra™ dressing

DEVICE

Cutimed® Sorbact®

Wound treatment with Cutimed® Sorbact® dressing

Sponsors & Collaborators

  • NAMSA

    collaborator OTHER

  • ConvaTec Inc.

    lead INDUSTRY

Principal Investigators

  • Catarina Saavedra, MD · Convatec Colombia Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-05
Primary Completion
2024-02-14
Completion
2024-02-14

Countries

  • Colombia
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05892341 on ClinicalTrials.gov